The Fund Manager wish to inform you that the First Replacement Singapore Prospectus of Fidelity Funds SICAV has been registered with the MAS effective today.
Kindly note that the effective date for this First Replacement Singapore Prospectus is 31 March 2022.
Need Assistance? Share your Details and we’ll get back to you
NOTICE:
You have clicked on a link which leaves POEMS website, and you will be redirected to a third party website. POEMS makes no representations nor has any supervision or control over the quality, content, reliability or security of the third party website, nor shall POEMS be liable for its use.
This is provided to you for general information only and does not constitute a recommendation, an offer or solicitation to buy or sell the investment product mentioned. It does not have any regard to your specific investment objectives, financial situation or any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of your acting based on this information.
Investments are subject to investment risks including the possible loss of the principal amount invested. Unit trusts distributed by Phillip Securities Pte Ltd (“PSPL”) are not obligations of, deposits in, or guaranteed by, PSPL or any of its affiliates.
The value of the units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in this publication are not necessarily indicative of future or likely performance of any unit trust. You should read the prospectus and product highlights sheet before deciding to subscribe for units in the respective fund. A copy of the prospectus can be obtained from the issuer or PSPL, or online at https://www.poems.com.sg/fund-finder/phillip-money-market-fund-534010/
You may wish to obtain advice from a qualified financial adviser, pursuant to a separate engagement, before making a commitment to purchase any of the investment products mentioned herein. In the event that you choose not to obtain advice from a qualified financial adviser, you should assess and consider whether the investment product is suitable for you before proceeding to invest and we do not offer any advice in this regard unless mandated to do so by way of a separate engagement.
This advertisement has not been reviewed by the Monetary Authority of Singapore.
Unlock Opportunities in a Sluggish Market Register Now4Q 2023 Strategy & Stock Picks
